...
【24h】

Carcinoma of the nasal cavity and paranasal sinuses.

机译:鼻腔和鼻旁窦癌。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVES/HYPOTHESIS: To determine the outcomes after radiotherapy (RT) alone or combined with surgery at the University of Florida for patients with carcinomas of the nasal cavity and paranasal sinuses. METHODS: Between November 1964 and June 2005, 109 patients were treated with curative intent. Patients with maxillary sinus carcinomas were excluded. Fifty-six patients were treated with definitive RT, and 53 patients received surgery and preoperative (eight patients) or postoperative (45 patients) RT. Median follow-up was 4.3 years (range, 0.2-35.9 years). Median follow-up on living patients was 9.4 years (range, 2.0-35.9 years). RESULTS: The 5-year local control rates were: T1-T3, 82%; T4, 50%; and overall, 63%. Local control at 5 years was 43% after definitive RT versus 84% after surgery and adjuvant RT (P < .0001). Multivariate analysis of local control revealed that both overall stage and treatment group (definitive RT versus surgery and adjuvant RT) significantly impacted this endpoint. Cause-specific survival rates were: stages I to III, 81%; stage IV, 54%; and overall, 62%. Multivariate analysis revealed that T-stage, N-stage, and treatment group significantly influenced this endpoint. Thirty-one (20%) of 109 patients sustained severe complications; 17 of 56 patients (16%) after definitive RT and 14 of 53 patients (25%) after surgery and adjuvant RT. CONCLUSIONS: The probability of local control and cause-specific survival is better after surgery and RT compared with definitive RT. There is a modest increase in the risk of complications after surgery and RT. Thus, the preferred treatment is surgery combined with preoperative or postoperative RT.
机译:目的/假设:为了确定鼻腔癌和鼻旁窦癌患者单独放疗或联合佛罗里达大学手术后的结果。方法:1964年11月至2005年6月,有109例患者接受了根治性治疗。排除上颌窦癌患者。 56例患者接受了明确的放疗,53例接受了手术和术前(8例)或术后(45例)放疗。中位随访时间为4.3年(范围0.2-35.9年)。对存活患者的中位随访时间为9.4年(范围2.0-35.9年)。结果:5年局部控制率是:T1-T3,82%; T4,50%;总体而言,占63%。确定性放疗后5年的局部控制率为43%,而手术和辅助放疗后为84%(P <.0001)。局部对照的多变量分析显示,整个阶段和治疗组(确定性放疗与手术和辅助放疗)均显着影响该终点。特定原因的生存率是:第一至第三阶段为81%;第四阶段,占54%;总体而言为62%。多变量分析显示,T期,N期和治疗组显着影响了该终点。 109名患者中有31名(20%)出现严重并发症;确定性放疗后56例患者中的17例(16%),手术和辅助放疗后53例患者中的14例(25%)。结论:与确定的RT相比,手术和RT后局部控制和特定病因生存的可能性更高。手术和放疗后发生并发症的风险适度增加。因此,首选的治疗方法是手术联合术前或术后放疗。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号